Rilexine (5 kg)
Active substance
ATC code
Species
Dogs and cats.
Indications
For the treatment of bacterial skin infections in dogs (including deep and superficial pyodermas) caused by organisms susceptible to Cefalexin.
For the treatment of cutaneous and subcutaneous infections (wounds and abscesses) in cats caused by organisms susceptible to Cefalexin.
For the treatment of urinary-tract infections in cats and dogs (including nephritis and cystitis) caused by organisms susceptible to Cefalexin.
Dose to be administered and administration route
15 mg of Cefalexin per kg of bodyweight twice daily (equivalent to 30 mg per kg of bodyweight per day) for a duration of:
- 5 days in case of cutaneous and subcutaneous infections (wounds and abscesses) in cats;
- 14 days in case of urinary-tract infection in cats and dogs;
- at least 15 days in case of superficial infectious dermatitis in dogs;
- at least 28 days in case of deep infectious dermatitis in dogs.
To achieve this dosage, administer:
in cats and dogs:
• one tablet per 5 kg of bodyweight or ½ tablet per 2.5 kg of bodyweight.
To ensure correct dosage, bodyweight should be determined as accurately as possible to avoid underdosing.
Due to its palatable formulation, the product is well accepted by cats and dogs but may be crushed or added to food if necessary.
In severe or acute conditions, the dose may be safely doubled.
Adverse reactions
Very rare cases of soft faeces and vomiting may be observed in animals during treatment.
Hypersensitivity to Cefalexin is rare, however, the product should not be administered to animals which are known to be hypersensitive to Cefalexin or penicillin. Refer also to section 4.3.
Allergic cross-reactivity with other β-lactams may occur.
References
Similar products
Showing 1 of 1 results
